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Available online 7 October 2016Over the last decade, clinicians have increasingly used
musculoskeletal ultrasound for the diagnosis and treatment
of rheumatic diseases, especially rheumatoid arthritis (RA).
High-resolution ultrasound of the musculoskeletal system is
a major tool for the diagnosis of arthritis because it pro-
vides visualization of abnormalities in the internal structure
of joints, including synovial hyperplasia, congestion, effu-
sion, cartilage loss, cortical bone erosion, tendon and lig-
ament injuries, and tenosynovitis. Ultrasound is, therefore,
dubbed the “third eye” of physicians, and learning to use
ultrasound is an important educational requirement for
rheumatologists. Rheumatologists have long acknowledged
the value of ultrasound for the diagnosis and treatment of
RA, and domestic rheumatologists who specialize in ultra-
sound have accumulated considerable experience in the
clinical use of ultrasound. The advantage of ultrasound is
that it provides visualization of subclinical synovitis that
cannot be detected by physical examination. In other
words, mild synovial swelling and effusion are often unde-
tectable on palpation due to the human physiological lim-
itation, so ultrasound helps in the early diagnosis of jointConflicts of interest: Nil.
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of cortical bone that cannot be recognized on X-ray and
coexisting tenosynovitis, which distinguishes RA from other
forms of arthritis. It is important to note that cortical bone
erosion, extensor carpi ulnaris tenosynovitis, and posterior
tibialis tenosynovitis are more common in patients with RA
[1]. Ultrasound is also a valuable treatment tool. In
particular, use of ultrasound to guide aspiration and in-
jection of joints can greatly increase the accuracy of local
therapy and prevent patients from the stress of repeated
needle-sticks.
In recent years, rheumatologists have placed greater
emphasis on early diagnosis and treatment to target for
patients with RA. If RA can be diagnosed in its early stages
(early RA) and appropriate medication(s) can be adminis-
tered, there is a greater chance of disease remission [2].
However, the best methods for diagnosis of RA in its early
stages and the use of ultrasound in early diagnosis are not
yet established.
In 2012, the author assessed the use of wrist joint ul-
trasound as a single diagnostic tool to distinguish RA from
non-RA. This assessment of the value of ultrasound for
diagnosis of RA indicated that vascularity invading bone
sign had high specificity (95.3%), but failed to meet the
requirements for early detection due to its low sensitivity
(52.1%). Early diagnosis of RA requires tool(s) with high
sensitivity and high specificity. This year, our research
team from the Department of Rheumatology at Taichung
Veterans General Hospital established 40-joint ultrasoundof Ultrasound in Medicine. This is an open access article under the
4.0/).
Figure 1 Ultrasound images of wrist joints in a 51-year-old female patient with rheumatoid arthritis. (A and B) Images showing
Grade 2 synovial hyperplasia and Grade 2 power Doppler signals in both wrist joints before tocilizumab administration. (C and D) In
both wrist joints, at Week 12 to tocilizumab therapy, synovial hyperplasia was downgraded from 2 to 1 and the power Doppler signal
score was reduced from 2 to 0. The disappearance of power Doppler signals demonstrates the therapeutic effect of biologic
tocilizumab.
130 K.-L. Laicoupled with 2010 American College of Rheumatology/
European League Against Rheumatism classification criteria
[3] for the diagnosis of RA. By taking the advantage
of ultrasound to visualize subclinical synovitis that cannot
be detected by physical examination, this approach assesses
synovitis in 40 joints (proximal interphalangeal joints,
metacarpophalangeal joints, wrist joints, elbow joints,
shoulder joints, knee joints, ankle joints, and meta-
tarsophalangeal joints) located at the upper and lower
limbs on both sides of the body in an effort to improve the
scoring of “joint involvement” in the diagnostic criteria,
thus increasing the diagnostic capability. Following the
implementation of 40-joint ultrasound, we found that our
method is particularly helpful for patients with seronega-
tive RA, those with palindromic rheumatism that subse-
quently evolves into RA, and those with RA but low
inflammatory indices.
For the assessment of treatment to target, a tool is
needed to assess disease activity, and achievement of the
therapeutic goal must be determined by the use of this
tool. The disease activity score in 28 joints (DAS28) is a
common clinical assessment tool that is calculated by
counts of tenderness in 28 joints (T28), counts of swelling in
28 joints (S28), erythrocyte sedimentation rate (ESR), andDAS28 Z 0.56  O(T28) þ 0.28  O(S28) þ 0.70  Ln(ESR) þ 0the patient’s assessment of general health (GH), using the
following formula:
A DAS28 score of <2.6 indicates clinical remissionda
treatment goal for RA. However, confounding factors un-
related to RA can influence DAS28, thus raising doubts
about the use of this metric.
This led to the use of ultrasound as an additional tool to
evaluate disease activity (Figure 1). Based on the 40-joint
ultrasound approach, synovitis in each joint was classified
on a scale of 0e3, and these scores were combined to
achieve a total disease activity score of 0e120 [4]. Mea-
surements in 37 patients with RA indicated a low correla-
tion between the DAS28 score and the 40-joint ultrasound
score. This disparity calls into question use of the DAS28
score as an assessment tool. In agreement, many studies
have reported that subclinical synovitis can be detected by
imaging of patients who have achieved clinical remission
(DAS28 < 2.6) after treatment, and such patients have a
greater chance of bone erosion in the long run [5,6]. We
also observed that some patients who apparently achieved
clinical remission after treatment with biologics still had
higher 40-joint ultrasound scores, so these patients were
not in true remission. Lastly, most of the literature sug-
gests using a power Doppler score of 0 for ultrasound-.014  (GH)
Ultrasound for Diagnosis and Treatment of RA 131defined remission, that is, no Doppler signals on synovium
in any examined joints [7e9]. We expect that power
Doppler ultrasound remission will become a new thera-
peutic goal for RA.References
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